Directory Affiliates and Chapters

John Mordaunt was a tireless advocate of HIV infected drug users. He was the first HIV+ drug user to be shown on national television in his country, England. Mordaunt helped to found the British advocacy organization for HIV infected drug users called Frontliners and was active with the European Interest Group on Drug Policy, a…

Federal Law Basic Information About DATA On October 17, 2000 Title XXXV of the Children’s Health Act of 2000 was enacted that permits the prescribing of schedule III, IV or V opioid treatment drugs that are approved by the FDA for maintenance or detoxification treatment. Read the full text: Public Law 106-310, Sec. 3502. Controlled…

James P. Connolly, CMA PA-NAMA and NAMA Newtown, PA Rebecca Ballard, CMA OK NAMA Tulsa, OK Carolyn Miranda, CMA NAMA SOCAL Fountain Valley, CA Changes in the service environment of MAT, expecially accreditation, are affecting relationships of patients, providers, and outside agencies. A panel of NAMA advocates will describe experiences with patient committees, staff advocacy…

National Methadone Conference AMTA 2001 Monday, October 8th, 11 am to 1 pm Chair Mark Parrino, American Methadone Treatment Association The Policy Maker’s Luncheon is an invitation only event that is attended by the federal and state agencies and national organizational representatives (i.e. ASAM, NAMA). Therefore no pictures were taken during the luncheon. The Policy…

National Alliance for Medication Assisted Recovery CONFIDENTIAL Grievance/Compliment Report All information that is provided will be held strictly confidential in the same manner as the patient protections described in the U.S. Federal Confidentiality Regulations 42 CFR and the Standards for Privacy of Individually Identifiable Health Information (the Privacy Rule) as established by the Department of…

FDA Warns About Orlaam T01-15 Print Media: 301-827-6242 April 20, 2001 Broadcast Media: 301-827-3434   Consumer Inquiries: 888-INFO-FDA The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With…